Continue s/c trial to 390???
I am correct? to state that some folks are behind in their research/reading, because
#1) we may not need to go to 390 before "another" Interim analysis, we may be allowed another Interim analysis when s/c enrollment reaches 240 or 255 etc and
#2) an FDA website was posted, revealing about 20 "pathways" for a drug to obtain FDA approval or EUA, and Tuesday may reveal and discuss and may pursue one of those, as a quick and maybe even "preferred" pathway